Two newly identified gene variants linked to breast cancer may aid in predicting disease risk and targeting screening and prevention strategies.
New therapeutic target for angiosarcoma – an aggressive, highly fatal tumor of the blood vessels – identified.
The spinal cord’s neuropeptide Y signaling pathway may be a good target for new pain therapeutics.
A rare, inherited mutation confers an eightfold increased risk of prostate cancer, a recent study shows.
Enhancing stem cell survival is key to improving cell-based therapies for regenerative medicine, and a new drug could help.
Study suggests that the “kynurenine” biochemical pathway could be a target for reducing delirium and coma in critically ill patients.